Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2012
03/07/2012EP2426123A1 Pyrazole-based cyanine dye containing quaternary ammonium cation
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2426109A1 Novel kinase inhibitors
03/07/2012EP2425840A1 Triazine derivatives and their therapeutical applications
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424858A1 Cxcr3 receptor antagonists
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP2201002B1 5-ht7 receptor antagonists
03/07/2012EP1979331B1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
03/07/2012EP1663994B1 Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012CN1835943B 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and uses thereof
03/07/2012CN102369197A 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as adp receptor antagonists
03/07/2012CN102369196A Azetidines as histamine h3 receptor antagonists
03/07/2012CN102369187A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
03/07/2012CN101891668B L-prolinamide derivative, preparation method and application of same
03/06/2012US8129543 Cyclic guanidine ionic liquid
03/06/2012US8129542 Copper-catalysed ligation of azides and acetylenes
03/06/2012US8129399 Aminopyrimidines useful as kinase inhibitors
03/06/2012US8129395 4,5-disubstituted-2-aryl pyrimidines
03/06/2012US8129394 Heteroaryl-substituted imidazole compounds and uses thereof
03/06/2012US8129391 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
03/06/2012US8129390 Carboxamide, sulfonamide and amine compounds and methods for using the same
03/06/2012US8129389 Substituted oxindole derivatives, medicaments containing the latter and use thereof
03/06/2012US8129388 Therapeutic agents useful for treating pain
03/06/2012US8129372 Compounds having NPY Y5 receptor antagonistic activity
03/06/2012CA2525628C New benzimidazole derivatives
03/06/2012CA2523245C Indole acetic acid derivatives and their use as pharmaceutical agents
03/06/2012CA2498754C Benzimidazolones and their use as cytokine inhibitors
03/01/2012WO2012027712A2 Potent and selective inhibitors of hepatitis c virus
03/01/2012WO2012027625A2 Scaffold-based polymerase enzyme substrates
03/01/2012WO2012027623A2 Cyanine dyes
03/01/2012WO2012027618A2 Functionalized cyanine dyes
03/01/2012WO2012027495A1 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012WO2012025811A1 Indolylpyrimidines as modulators of gpr119
03/01/2012WO2012025772A1 Process for preparing pure 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole, intermediate for eletriptan
03/01/2012WO2012025726A1 Novel Hybrid Compounds
03/01/2012WO2012025473A1 Cc.chemokine receptor 4 antagonists
03/01/2012WO2012025164A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2011139022A3 Benzindocyanine compound used for substance marking, an intermediate production product thereof and a production method therefor
03/01/2012WO2011136510A3 Novel method for preparing losartan metabolite exp-3174 dihydrate
03/01/2012WO2011117806A3 Pyridazine compounds for controlling invertebrate pests
03/01/2012US20120053345 Indazole Compounds
03/01/2012US20120053195 Hydrobromide salts of a pyrazolylaminoquinazoline
03/01/2012US20120053188 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
03/01/2012US20120053183 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012US20120053180 Cyclohexane analogues as gpr119 agonists
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053174 Quinazoline compounds and methods of use thereof
03/01/2012US20120053165 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053150 N-pyrazolyl carboxamides as crac channel inihibitors
03/01/2012US20120052506 Cyanine dyes
03/01/2012US20120052096 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/01/2012CA2809261A1 Potent and selective inhibitors of hepatitis c virus
03/01/2012CA2809256A1 Compounds for treatment of cancer
03/01/2012CA2807738A1 Hydroxamate-based inhibitors of deacetylases
02/2012
02/29/2012EP2423209A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
02/29/2012EP2423207A2 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
02/29/2012EP2423202A1 Triazine-based compound and ultraviolet absorber
02/29/2012EP2423199A1 Substituted imidazoles and their use as pesticides
02/29/2012EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism
02/29/2012EP2422788A2 Benzodiazepines and compositions and uses thereof
02/29/2012EP2421867A2 Piperidine inhibitors of janus kinase 3
02/29/2012EP2421855A1 Diaryl ethers
02/29/2012EP2421854A1 Inhibitors of bruton's tyrosine kinase
02/29/2012EP2421853A1 Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole
02/29/2012EP2421852A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
02/29/2012EP2421851A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421850A1 3 -azabicyclo [4.1.0]heptanes used as orexin antagonists
02/29/2012EP2421848A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421845A1 Antiviral compounds and uses thereof
02/29/2012EP2421829A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP2421826A1 Proline derivatives as cathepsin inhibitors
02/29/2012EP2421825A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421824A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2421823A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/29/2012EP2323980B1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
02/29/2012EP2123649B1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
02/29/2012EP2049116B1 Hepatitis c virus inhibitors
02/29/2012EP1953148B1 Heterocyclic amide compound and use thereof
02/29/2012EP1636208B1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
02/29/2012CN102365271A Heterocyclic compounds as autotaxin inhibitors
02/29/2012CN101679309B Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
02/28/2012US8124791 Active energy ray curable liquid composition and liquid cartridge
02/28/2012US8124789 Method for producing glycosylated indole compound and antibody against the compound
02/28/2012US8124766 Inhibitors of diacylglycerol acyltransferase
02/28/2012US8124765 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
02/28/2012US8124647 Non-steroidal androgens compounds
02/28/2012US8124639 Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/28/2012US8124602 Compounds for the treatment of multi-drug resistant bacterial infections
02/28/2012CA2501335C Compounds capable of activating cholinergic receptors
02/23/2012WO2012024670A2 Composition and methods for treating glioblastoma
02/23/2012WO2012024373A1 Compounds for the treatment of hepatitis c
02/23/2012WO2012024029A1 Controlling concentrations of anions with light using aryl-triazole foldamers
02/23/2012WO2012023947A1 Bicarbazole compounds for oleds
02/23/2012WO2012022795A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
02/23/2012WO2012022408A1 Pyrimidine derivatives as fak inhibitors
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 626